HUT63858A - Process for producing new insulin complexes - Google Patents
Process for producing new insulin complexes Download PDFInfo
- Publication number
- HUT63858A HUT63858A HU922721Q HU272191Q HUT63858A HU T63858 A HUT63858 A HU T63858A HU 922721 Q HU922721 Q HU 922721Q HU 272191 Q HU272191 Q HU 272191Q HU T63858 A HUT63858 A HU T63858A
- Authority
- HU
- Hungary
- Prior art keywords
- insulin
- iii
- cobalt
- mixture
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Chairs For Special Purposes, Such As Reclining Chairs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK045590A DK45590D0 (OSRAM) | 1990-02-21 | 1990-02-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9202721D0 HU9202721D0 (en) | 1992-12-28 |
| HUT63858A true HUT63858A (en) | 1993-10-28 |
Family
ID=8093754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU922721Q HUT63858A (en) | 1990-02-21 | 1991-02-21 | Process for producing new insulin complexes |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0516704B1 (OSRAM) |
| JP (1) | JPH05503940A (OSRAM) |
| AU (1) | AU641991B2 (OSRAM) |
| CA (1) | CA2075982A1 (OSRAM) |
| DE (1) | DE69100626D1 (OSRAM) |
| DK (1) | DK45590D0 (OSRAM) |
| HU (1) | HUT63858A (OSRAM) |
| IE (1) | IE910579A1 (OSRAM) |
| NZ (1) | NZ237176A (OSRAM) |
| PT (1) | PT96841A (OSRAM) |
| WO (1) | WO1991012817A1 (OSRAM) |
| ZA (1) | ZA911279B (OSRAM) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9316895D0 (en) * | 1993-08-13 | 1993-09-29 | Guy S And St Thomas Hospitals | Hepatoselective insulin analogues |
| US6342225B1 (en) | 1993-08-13 | 2002-01-29 | Deutshces Wollforschungsinstitut | Pharmaceutical active conjugates |
| AU682061B2 (en) * | 1993-09-17 | 1997-09-18 | Novo Nordisk A/S | Acylated insulin |
| US6011007A (en) * | 1993-09-17 | 2000-01-04 | Novo Nordisk A/S | Acylated insulin |
| US6869930B1 (en) | 1993-09-17 | 2005-03-22 | Novo Nordisk A/S | Acylated insulin |
| US6251856B1 (en) | 1995-03-17 | 2001-06-26 | Novo Nordisk A/S | Insulin derivatives |
| US6451762B1 (en) | 1997-10-24 | 2002-09-17 | Novo Nordisk A/S | Aggregates of human insulin derivatives |
| EP2264065B1 (en) | 2003-08-05 | 2017-03-08 | Novo Nordisk A/S | Novel insulin derivatives |
| KR101186851B1 (ko) | 2003-08-05 | 2012-10-02 | 노보 노르디스크 에이/에스 | 신규의 인슐린 유도체 |
| EP2256130B1 (en) | 2005-02-02 | 2013-09-25 | Novo Nordisk A/S | Novel insulin derivatives |
| ATE519780T1 (de) | 2005-12-28 | 2011-08-15 | Novo Nordisk As | Ein acyliertes insulin und zink enthaltende zusammensetzungen und verfahren zur herstellung dieser zusammensetzungen |
| WO2008015099A2 (en) | 2006-07-31 | 2008-02-07 | Novo Nordisk A/S | Pegylated, extended insulins |
| AU2007298919C1 (en) | 2006-09-22 | 2014-02-06 | Novo Nordisk A/S | Protease resistant insulin analogues |
| US9387176B2 (en) | 2007-04-30 | 2016-07-12 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
| WO2008152106A1 (en) | 2007-06-13 | 2008-12-18 | Novo Nordisk A/S | Pharmaceutical formulation comprising an insulin derivative |
| WO2009112583A2 (en) | 2008-03-14 | 2009-09-17 | Novo Nordisk A/S | Protease-stabilized insulin analogues |
| CA2718738C (en) | 2008-03-18 | 2019-05-07 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
| ES2607003T3 (es) | 2008-10-30 | 2017-03-28 | Novo Nordisk A/S | Tratamiento de diabetes mellitus utilizando inyecciones de insulina con una frecuencia de inyección inferior a la diaria |
| BR112013010345A2 (pt) | 2010-10-27 | 2017-07-25 | Novo Nordisk As | tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção |
| US9481721B2 (en) | 2012-04-11 | 2016-11-01 | Novo Nordisk A/S | Insulin formulations |
| JP2016519127A (ja) | 2013-04-30 | 2016-06-30 | ノヴォ ノルディスク アー／エス | 新規投与レジメン |
| WO2015052088A1 (en) | 2013-10-07 | 2015-04-16 | Novo Nordisk A/S | Novel derivative of an insulin analogue |
| ES2930149T3 (es) | 2016-12-16 | 2022-12-07 | Novo Nordisk As | Composiciones farmacéuticas que contienen insulina |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| US12343383B2 (en) | 2019-07-12 | 2025-07-01 | Novo Nordisk A/S | High concentration insulin formulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE971500C (de) * | 1950-11-22 | 1959-02-05 | Organon Nv | Verfahren zur Herstellung von Insulin-Suspensionen mit verlaengerter Wirkung |
| DE1107374B (de) * | 1958-01-31 | 1961-05-25 | Organon Nv | Verfahren zur Herstellung eines Insulin-Praeparates |
-
1990
- 1990-02-21 DK DK045590A patent/DK45590D0/da not_active Application Discontinuation
-
1991
- 1991-02-20 IE IE057991A patent/IE910579A1/en unknown
- 1991-02-20 NZ NZ237176A patent/NZ237176A/en unknown
- 1991-02-21 AU AU73378/91A patent/AU641991B2/en not_active Expired - Fee Related
- 1991-02-21 ZA ZA911279A patent/ZA911279B/xx unknown
- 1991-02-21 WO PCT/DK1991/000052 patent/WO1991012817A1/en active IP Right Grant
- 1991-02-21 JP JP3504590A patent/JPH05503940A/ja active Pending
- 1991-02-21 PT PT96841A patent/PT96841A/pt not_active Application Discontinuation
- 1991-02-21 CA CA002075982A patent/CA2075982A1/en not_active Abandoned
- 1991-02-21 DE DE91904980T patent/DE69100626D1/de not_active Expired - Lifetime
- 1991-02-21 HU HU922721Q patent/HUT63858A/hu unknown
- 1991-02-21 EP EP91904980A patent/EP0516704B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NZ237176A (en) | 1991-12-23 |
| WO1991012817A1 (en) | 1991-09-05 |
| AU641991B2 (en) | 1993-10-07 |
| JPH05503940A (ja) | 1993-06-24 |
| EP0516704A1 (en) | 1992-12-09 |
| EP0516704B1 (en) | 1993-11-10 |
| PT96841A (pt) | 1991-11-29 |
| HU9202721D0 (en) | 1992-12-28 |
| AU7337891A (en) | 1991-09-18 |
| DK45590D0 (OSRAM) | 1990-02-21 |
| CA2075982A1 (en) | 1991-08-22 |
| DE69100626D1 (de) | 1993-12-16 |
| IE910579A1 (en) | 1991-08-28 |
| ZA911279B (en) | 1991-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT63858A (en) | Process for producing new insulin complexes | |
| DE69429169T2 (de) | Pharmazeutisches präparat, das heparin, heparinfragmente oder -derivate in kombination mit glycerinestern enthält | |
| US4877778A (en) | Method of enhancing lipophile transport using cyclodextrin derivatives | |
| DE3880346T2 (de) | Insulinderivate. | |
| DE69815877T2 (de) | Aggregate von menschlichen insulinderivaten | |
| KR890004687B1 (ko) | 생물학적 활성 서방출성 조성물 | |
| EP1274459A2 (en) | Sustained release formulations comprising growth hormone | |
| HUT67853A (en) | Insulin formulation | |
| AU2001259111A1 (en) | Sustained release formulations comprising growth hormone | |
| CN1556712A (zh) | 含dds化合物的药用组合物 | |
| EP3821905A1 (en) | Insulin containing pharmaceutical compositions | |
| CA1335924C (en) | Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus | |
| HUT59942A (en) | Process for producing glycozylized inzulines | |
| JP6920471B2 (ja) | 迅速に作用するインスリン組成物 | |
| EP3834818B1 (en) | Stable infusion solution composition containing sugar and amino acid | |
| EP1620072B1 (en) | Zinc-containing sustained-release composition, its preparation, and method for producing the same | |
| JP2716497B2 (ja) | ヘモグロビン コンプレツクス | |
| JPH09124512A (ja) | 肝臓ターゲティングのための水溶性の薬物−プルラン結合体製剤 | |
| EP3996679A1 (en) | High concentration insulin formulation | |
| JPH0363299A (ja) | 修飾エリスロポエチン | |
| HK40016003B (en) | Rapid-acting insulin compositions | |
| JPS61251627A (ja) | 非経口的投与のための水分散性および水溶性のポリマ−組成物 | |
| HRP930063A2 (en) | Novel compositions containing hyaluronic acid associates and a process for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFC9 | Refusal of application |